Perceptive Advisors LLC Mereo Biopharma Group PLC Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
A detailed history of Perceptive Advisors LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Perceptive Advisors LLC holds 815,722 shares of MREO stock, worth $3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
815,722
Previous 1,253,250
34.91%
Holding current value
$3 Million
Previous $4.51 Million
25.69%
% of portfolio
0.09%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding MREO
# of Institutions
84Shares Held
107MCall Options Held
209KPut Options Held
479K-
Rubric Capital Management LP New York, NY15.3MShares$56.3 Million1.75% of portfolio
-
Janus Henderson Group PLC London, X012.3MShares$45.4 Million0.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.72MShares$35.8 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.53MShares$35.1 Million1.33% of portfolio
-
Mangrove Partners New York, NY8.73MShares$32.1 Million4.66% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $460M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...